| For: | Fan JQ, Zhao WF, Lu QW, Zha FR, Lv LB, Ye GL, Gao HL. Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer. World J Gastrointest Oncol 2023; 15(8): 1424-1435 [PMID: 37663945 DOI: 10.4251/wjgo.v15.i8.1424] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i8/1424.htm |
| Number | Citing Articles |
| 1 |
Hongli Zhou, Yupei Zhuang, Yuwei Liang, Haibin Chen, Wenli Qiu, Huiqin Xu, Hongguang Zhou. Curcumin exerts anti-tumor activity in colorectal cancer via gut microbiota-mediated CD8+ T Cell tumor infiltration and ferroptosis. Food & Function 2025; 16(9) doi: 10.1039/D4FO04045G
|
| 2 |
Minghui Yu, Xin Shi, Dong Li, Yuelin Li, Mingyu Sun. Spatial niches of the colorectal cancer microbiome: differences, interrelationships, and clinical implications of fecal, mucosal, and intratumoral microbiota. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1904188
|
| 3 |
Jerome Prusa, Mark G. Gorelik, Kevin S. Blake, Gautam Dantas. State of omics-based microbial diagnostics of CRC. Gut Microbes 2025; 17(1) doi: 10.1080/19490976.2025.2526132
|
| 4 |
Minkwan Kim, Donghyeon Gim, Sunghan Kim, Sungsu Park, Tehyun Phillip Eom, Jaehoon Seol, Junyeong Yeo, Changmin Jo, Gunha Seo, Hyungjune Ku, Jae Hyun Kim. From Dysbiosis to Prediction: AI-Powered Microbiome Insights into IBD and CRC. Gastroenterology Insights 2025; 16(3) doi: 10.3390/gastroent16030034
|
| 5 |
Min Guo, Xin-chi Zhang, Dong-fei Guo, Sai-xue Wei, Jian-nan Cao, Xiao-dong Li, De-wen Liu. Polysaccharide of Danggui Buxue Decoction Attenuates Colorectal Cancer via Modulating Intestinal Microflora and Metabolites. Chinese Journal of Integrative Medicine 2026; 32(3) doi: 10.1007/s11655-025-3833-x
|
| 6 |
Sara Haddou Bouazza. A Deep Ensemble Gene Selection and Attention-guided Classification Framework for Robust Cancer Diagnosis from Microarray Data. Engineering, Technology & Applied Science Research 2025; 15(1) doi: 10.48084/etasr.9476
|
| 7 |
Pankaj Chejara, Anders Eriksson. Gut microbiome biomarkers for colorectal cancer detection: a systematic review highlighting age as a key confounder. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1810802
|
| 8 |
Arturo Loaiza-Bonilla, Yan Leyfman, Viviana Cortiana, Rhys Crawford, Shivani Modi. Defining a Multi-Omic, AI-Enabled Stool Screening Paradigm for Colorectal Cancer: A Consensus Framework for Clinical Translation. Cancers 2026; 18(6) doi: 10.3390/cancers18060909
|
| 9 |
Changwei Duan, Jianqiu Sheng, Xianzong Ma. Innovative approaches in colorectal cancer screening: advances in detection methods and the role of artificial intelligence. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848251314829
|
| 10 |
Mohammad Yasin Zamanian, Darmadi Darmadi, Razieh Darabi, Raed Fanoukh Aboqader Al-Aouadi, Mehraveh Sadeghi Ivraghi, Esra Küpeli Akkol. Biomarkers for colorectal cancer detection: An insight into colorectal cancer and FDA-approved biomarkers. BioImpacts 2025; 15 doi: 10.34172/bi.31211
|
| 11 |
Ismail Amin, Atef S. Elgebaly, Hend H. Mohamed, Khaled Abuelhaded, Khaled M. Alam-ElDein, Ahmed Kamel Ibrahim, Shimaa A. Farag, Alaa Adel, Mona Hamdy, Mohamed Elkhawanky, Ahmed Mahdy. Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology. Clinical and Translational Oncology 2026; doi: 10.1007/s12094-026-04500-8
|
| 12 |
Fan Liu, Xingbing Lu, Mengli Tang, Yuzuo Chen, Xi Zheng. Gut Microbiome and Metabolite Characteristics Associated With Different Clinical Stages in Non-Small Cell Lung Cancer Patients. Cancer Management and Research 2025; doi: 10.2147/CMAR.S499003
|
| 13 |
Bruno Menezes Teixeira Campos, Ana Beatriz De Mello Domingos, Lara Oliveira Holak dos Santos, Bruna Cristina Moreira Santos, Adriana Rodrigues Ferraz. Modulações da microbiota fecal como fator de risco e quantificação prognóstica para câncer colorretal: uma revisão de literatura. Revista Saber Digital 2025; 18(1) doi: 10.24859/SaberDigital.2025v18n1.1644
|
| 14 |
Sherlyn Jemimah, Amin F. Majdalawieh, Mawieh Hamad, Amjad A. Mahasneh. Differential analysis of microbial profiles in colorectal cancer reveals modulations corresponding to immune subtypes. Computers in Biology and Medicine 2026; 200 doi: 10.1016/j.compbiomed.2025.111346
|
| 15 |
Abhishek Kumar Karn, Md. Asad Quasim, El Bethel Lalthavel Hmar, Sujata Paul, H.K. Sharma. Diagnostic Landscape in Cancer Research. 2025; doi: 10.1016/B978-0-443-33849-6.00009-X
|
| 16 |
Conghan Li, Panyin Shu, Taiyu Shi, Yuerong Chen, Ping Mei, Yizhong Zhang, Yan Wang, Xinyan Du, Jianning Wang, Yixin Zhang, Bin Liu, Zhijin Sheng, Shixin Chan, Zhangyong Dan. Predicting the potential deterioration of Barrett’s esophagus based on gut microbiota: a Mendelian randomization analysis. Mammalian Genome 2024; 35(3) doi: 10.1007/s00335-024-10042-7
|
| 17 |
Yan-Qiu Bao, Ying Zhang, Zhou-Na Li. Causal associations between gut microbiota and cutaneous melanoma: a Mendelian randomization study. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1339621
|
| 18 |
Majid Eslami, Ramtin Naderian, Aisa Bahar, Ali Babaeizad, Solaleh Rezanavaz Gheshlagh, Valentyn Oksenych, Hamed Tahmasebi. Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1559480
|
| 19 |
Sergio Ruiz-Saavedra, Silvia Arboleya, Alicja M. Nogacka, Carmen González del Rey, Adolfo Suárez, Ylenia Diaz, Miguel Gueimonde, Nuria Salazar, Sonia González, Clara G. de los Reyes-Gavilán. Commensal Fecal Microbiota Profiles Associated with Initial Stages of Intestinal Mucosa Damage: A Pilot Study. Cancers 2023; 16(1) doi: 10.3390/cancers16010104
|
| 20 |
泽旭 杨. Research Progress of Intestinal Flora
as an Early Diagnostic Marker of
Colorectal Cancer. Advances in Clinical Medicine 2026; 16(05) doi: 10.12677/acm.2026.1652030
|
| 21 |
Lucansky Vincent, Pecova Renata, Pec Martin, Samec Marek. Characterization of Plasmids Isolated from Bacterial Flora of CRC Patients – Proof of Concept. Acta Medica Martiniana 2024; 24(1) doi: 10.2478/acm-2024-0003
|
| 22 |
Xiaoxue Wang, Zhichao Li, Haiquan Zhou, Qianyi Liu, Xueyang Zhang, Fei Hu. Periodontitis Exacerbates Colorectal Cancer by Altering Gut Microbiota–Derived Metabolomics in Mice. Journal of Periodontal Research 2025; 60(12) doi: 10.1111/jre.13380
|
| 23 |
Elias N. Katsoulieris, Paraskevi Ioannou, Nikolaos A. Afratis. Targeting the microbiota‐miRNA‐protease axis: A new therapeutic avenue in melanoma. The FEBS Journal 2026; 293(13) doi: 10.1111/febs.70386
|
| 24 |
Georgios Alampritis, Sarah Nohelia Thoukididou, Maria Ramos, Pantelis Georgiou, Melpomeni Kalofonou, Constantinos Simillis. Diagnostic value of genetic and epigenetic biomarker panels for colorectal cancer detection: a systematic review. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-04904-y
|
| 25 |
Shiyu Li, Jie Wang, Lijing Zhang, Pengchun Yang, Jing Wang, Caihua Yan, Diandian Chen, Yueying Huang, Chibing Dai. The bidirectional relationship between gut microbiota and the development of colorectal cancer. Current Proteomics 2026; 23(5) doi: 10.1016/j.curpro.2026.100163
|
| 26 |
Ippokratis Messaritakis, Andreas Koulouris, Eleni Boukla, Konstantinos Vogiatzoglou, Ilias Lagkouvardos, Evangelia Intze, Maria Sfakianaki, Maria Chondrozoumaki, Michaela Karagianni, Elias Athanasakis, Evangelos Xynos, John Tsiaoussis, Manousos Christodoulakis, Matthaios E. Flamourakis, Eleni S. Tsagkataki, Linda Giannikaki, Evdoxia Chliara, Dimitrios Mavroudis, Maria Tzardi, John Souglakos. Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis. Cancers 2024; 16(10) doi: 10.3390/cancers16101923
|
| 27 |
Abhiram Kumar, Anjali Rai, Shivang Shukla, Chhavi Dhiman, Kumar Pranav Narayan. Enhancing Autonomous and Adaptive Systems With AI and IoT. Advances in Computational Intelligence and Robotics 2025; doi: 10.4018/979-8-3373-3146-1.ch012
|